Aziridine → HCID 11279428, compound
Reaction equation
Cl[C:2]1[C:3]([N+:21]([O-:23])=[O:22])=[CH:4][C:5]([N+:18]([O-:20])=[O:19])=[C:6]([CH:17]=1)[C:7]([NH:9][CH2:10][CH2:11][N:12]1[CH:16]=[CH:15][N:14]=[CH:13]1)=[O:8].[NH:24]1[CH2:26][CH2:25]1>C1COCC1>[N:24]1([C:2]2[C:3]([N+:21]([O-:23])=[O:22])=[CH:4][C:5]([N+:18]([O-:20])=[O:19])=[C:6]([CH:17]=2)[C:7]([NH:9][CH2:10][CH2:11][N:12]2[CH:16]=[CH:15][N:14]=[CH:13]2)=[O:8])[CH2:26][CH2:25]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A stirred suspension of the above benzamide (150 mg, 0.44 mmol) in THF (40 mL) was treated with aziridine (91 μL, 1.76 mmol) at room temperature for 4 h, then additional aziridine (91 μL) was added. After a further 4 h, the mixture was concentrated under reduced pressure below 25° C., and the residue was partitioned between EtOAc and saturated NaCl. Evaporation of the organic layer gave a product that was triturated with EtOAc then recrystallized from MeCN/EtOAc/petroleum ether to give 7 (56 mg, 37%): mp >250° C.; 1H NMR [(CD3)2SO] δ8.91 (t, J=5.6 Hz, 1H, NH), 8.66 (s, 1H, H-3), 7.67 (s, 1H, imidazole-H), 7.29 (s, 1H, H-6), 7.24 & 6.93 (2xs, 2H, imidazole-H), 4 16 (t, J=5.9 Hz, 2H, NHCH2CH2), 3 62-3.51 (m, 2H, NHCH2), 2.49 (s, 4H, aziridine-H). Anal. Calcd. for C14H14N6O5: C, 48.55;H, 4.07; N, 24.27. Found: C, 48.69;H, 4.00; N, 24.10%.
Workup
- concentrationthe mixture was concentrated under reduced pressure below 25° C.
- customthe residue was partitioned between EtOAc and saturated NaCl
- customEvaporation of the organic layer
- customgave a product that
- customwas triturated with EtOAc
- customthen recrystallized from MeCN/EtOAc/petroleum ether
Sources & evidence
- ORD record
- ord-248c82330f7a44299127d69de4d1f460
- Source dataset
- uspto-grants-2003_02
- Patent number
- US06517836B1
Reaction notes
Loading…